Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:0874)

Paramount Global Revenue

Guangzhou Baiyunshan Pharmaceutical Holdings Company had revenue of 22.47B CNY in the quarter ending March 31, 2025, a decrease of -2.06%. This brings the company's revenue in the last twelve months to 74.52B, down -3.01% year-over-year. In the year 2024, Guangzhou Baiyunshan Pharmaceutical Holdings Company had annual revenue of 74.99B, down -0.69%.

• Revenue (ttm): 74.52B CNY
• Revenue Growth: -3.01%
• P/S Ratio: 0.56
• Revenue / Employee: 2.66M CNY
• Employees: 28,048
• Market Cap: 45.14B USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	74.99B	-522.58M	-0.69%
Dec 31, 2023	75.52B	4.73B	6.68%
Dec 31, 2022	70.79B	1.77B	2.57%
Dec 31, 2021	69.01B	7.34B	11.90%
Dec 31, 2020	61.67B	-3.28B	-5.05%